| Aktie | Ticker | Breite | GCS | 2025/Q3 | |||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 15.058.740 $ | +11.787.504 $ | -8,1 % | 9 | ||||
| XBP Global Holdings, Inc. | XBP | → 0 | 9.771.081 $ | +9.771.081 $ | 1 | ||
| HYPERION DEFI, INC. | HYPD | → 0 | Neutral | 2.300.388 $ | +2.300.388 $ | 1 | |
| NextDecade Corp | NEXT | → 0 | Schwach | 1.726.493 $ | -539.053 $ | -23,8 % | 1 |
| DarioHealth Corp. | DRIO | → 0 | 403.318 $ | +91.830 $ | +29,5 % | 1 | |
| Valion Bio, Inc. | TIVC | → 0 | 293.734 $ | +293.734 $ | 1 | ||
| Forge Global Holdings, Inc. | FRGE | → 0 | 192.035 $ | -24.317 $ | -11,2 % | 1 | |
| Beyond Air, Inc. | XAIR | → 0 | 189.305 $ | -93.098 $ | -33,0 % | 1 | |
| Orchestra BioMed Holdings, Inc. | OBIO | → 0 | Stark | 150.955 $ | -12.174 $ | -7,5 % | 1 |
| Rani Therapeutics Holdings, Inc. | RANI | → 0 | Stark | 31.431 $ | -887 $ | -2,7 % | 1 |
| 15.058.740 $ | +11.787.504 $ | -8,1 % | 9 | ||||